ArticleFrontiers in oncology2020

High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study.

Anniina Jääskeläinen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.